FilingSEC EDGAR6-K
Purple Biotech Appoints Isaac Israel as Interim CEO
· SEC accepted
StageManagement Change
Filing content
The Board of Directors appointed Isaac Israel as Interim CEO, while former CEO Gil Efron transitions to Head of Corporate Development.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…